Filana Therapeutics, Inc. (FLNA)
NASDAQ: FLNA · Real-Time Price · USD
1.560
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Filana Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 75 | 96 | 114 | 949 | 1,233 | 1,749 | |
| Market Cap Growth | 22.74% | -15.76% | -88.04% | -22.98% | -29.52% | 633.58% | |
| Enterprise Value | -20 | -10 | -35 | 807 | 1,058 | 1,507 | |
| Last Close Price | 1.56 | 1.98 | 2.36 | 22.51 | 29.54 | 43.70 | |
| Forward PE | - | - | - | 68.21 | - | - | |
| PB Ratio | 1.01 | 1.29 | 0.78 | 6.91 | 5.42 | 6.89 | |
| P/TBV Ratio | 1.02 | 1.29 | 0.78 | 6.92 | 5.43 | 6.92 | |
| Debt / Equity Ratio | - | - | - | - | 0.00 | 0.00 | |
| Net Debt / Equity Ratio | -1.28 | -1.28 | -0.88 | -0.88 | -0.88 | -0.92 | |
| Net Debt / EBITDA Ratio | 1.61 | 1.61 | 0.86 | 1.16 | 2.55 | 7.21 | |
| Net Debt / FCF Ratio | 2.91 | 2.91 | 1.10 | 1.47 | 2.50 | 4.45 | |
| Quick Ratio | 2.18 | 2.18 | 11.02 | 8.60 | 28.46 | 18.62 | |
| Current Ratio | 2.23 | 2.23 | 11.62 | 9.13 | 29.91 | 19.51 | |
| Return on Equity (ROE) | -82.66% | -82.66% | -17.19% | -53.27% | -31.67% | -18.71% | |
| Return on Assets (ROA) | -27.23% | -27.23% | -61.19% | -34.30% | -19.94% | -11.38% | |
| Return on Capital Employed (ROCE) | -80.60% | -80.60% | -103.80% | -77.20% | -35.10% | -12.90% | |
| Earnings Yield | -120.72% | -95.11% | -21.44% | -10.24% | -6.19% | -1.85% | |
| FCF Yield | -43.57% | -34.33% | -103.08% | -8.68% | -6.51% | -3.00% | |
| Buyback Yield / Dilution | -3.63% | -3.63% | -11.14% | -4.30% | -2.02% | -50.95% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.